Back

Hepatocyte growth factor as a new marker of pulmonary hypertension in heart failure patients.

23 May 2022 (08:30 - 19:45)
Organised by:
Congress Presentation Part of: Heart Failure ePosters - focus on Chronic Heart Failure 7 Biomarkers HFA Premium Access Heart Failure 2022

About the speaker

Photo
Doctor Piotr Cyganski

University of Warmia and Mazury in Olsztyn, Olsztyn (Poland)

34 More presentations in this session

Presentation thumbnail
Impact of socioeconomic status in medical resource use and outcomes in patients with heart failure managed in integrated care settings: a population-based pragmatic evaluation in 77,554 patients.
Doctor J. Comin-Colet (Barcelona, ES)
Abstract Slides
Presentation thumbnail
Sex differences in clinical characteristics and outcomes after acute myocardial infarction: insights from PARADISE-MI
Doctor X. Wang (Boston, US)
Abstract Slides
Presentation thumbnail
Uncontrolled asistole donation. Impact on primary graft failure and heart transplantation survival
Doctor V. Donoso (Valencia, ES)
Abstract Slides
Presentation thumbnail
Handheld echocardiography in outpatient heart failure clinics: facilitating prompt heart failure treatment
Doctor K. Somarakis (Leicester, GB)
Abstract Slides
Presentation thumbnail
Outcomes related to hyponatraemia and effects of dapagliflozin: findings from DAPA-HF
Doctor S. Yeoh (Glasgow, GB)
Abstract Slides

Access the full session

Session thumbnail
Heart Failure ePosters - focus on Chronic Heart Failure 7

The Event

Event poster

Heart Failure 2022

23 May 2022 08:30 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources